2-{[6-(adamantan-1-yl)-3-cyanopyridin-2-yl]sulfanyl}-N-(1,3-benzothiazol-2-yl)acetamide

Catalog No. :
ACHTNO498
CAS No. :
313379-93-0
Molecular Formula :
C25H24N4OS2
Molecular Weight :
460.63

IUPAC Name:2-((6-(adamantan-1-yl)-3-cyanopyridin-2-yl)thio)-N-(benzo[d]thiazol-2-yl)acetamide

2-{[6-(adamantan-1-yl)-3-cyanopyridin-2-yl]sulfanyl}-N-(1,3-benzothiazol-2-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$215.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{[6-(adamantan-1-yl)-3-cyanopyridin-2-yl]sulfanyl}-N-(1,3-benzothiazol-2-yl)acetamide
IUPAC Name2-((6-(adamantan-1-yl)-3-cyanopyridin-2-yl)thio)-N-(benzo[d]thiazol-2-yl)acetamide
MDL No.MFCD01789094
Molecular FormulaC25H24N4OS2
Molecular Weight460.63
SMILESO=C(NC1=NC2=CC=CC=C2S1)CSC3=NC(C45CC6CC(C5)CC(C6)C4)=CC=C3C#N
InChI KeyFQLHKSDBAIXWFG-UHFFFAOYSA-N
Synonym2-{[6-(1-adamantyl)-3-cyanopyridin-2-yl]sulfanyl}-N-(1,3-benzothiazol-2-yl)acetamide
CAS No.313379-93-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHTNO498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLZNR081 route compound structure diagram
    ACLZNR08194787-08-3 In Stock
  4. Then
  5. ACHTNO498 route product structure diagram
    ACHTNO498313379-93-0
Inquiry

2. ACHTNO498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHTNO498 route product structure diagram
    ACHTNO498313379-93-0
Inquiry

Comments (0)